Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Sponsor: Deciphera Pharmaceuticals, LLC
Summary
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT. This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participants.
Official title: Real-World Patient Experience of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-09-03
Completion Date
2027-09
Last Updated
2025-11-05
Healthy Volunteers
No
Conditions
Locations (1)
Synexus Clinical Research, US INC
Wilmington, North Carolina, United States